BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2405 related articles for article (PubMed ID: 8097496)

  • 1. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation.
    Saiki I; Fujii H; Yoneda J; Abe F; Nakajima M; Tsuruo T; Azuma I
    Int J Cancer; 1993 Apr; 54(1):137-43. PubMed ID: 8097496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).
    Yoneda J; Saiki I; Fujii H; Abe F; Kojima Y; Azuma I
    Clin Exp Metastasis; 1992 Jan; 10(1):49-59. PubMed ID: 1733647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.
    Ashmun RA; Look AT
    Blood; 1990 Jan; 75(2):462-9. PubMed ID: 1967220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.
    Fujii H; Nakajima M; Saiki I; Yoneda J; Azuma I; Tsuruo T
    Clin Exp Metastasis; 1995 Sep; 13(5):337-44. PubMed ID: 7641419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells.
    Menrad A; Speicher D; Wacker J; Herlyn M
    Cancer Res; 1993 Mar; 53(6):1450-5. PubMed ID: 8095183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
    Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I
    Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors.
    Fujii H; Nakajima M; Aoyagi T; Tsuruo T
    Biol Pharm Bull; 1996 Jan; 19(1):6-10. PubMed ID: 8820902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable O-glycosylation of CD13 (aminopeptidase N).
    O'Connell PJ; Gerkis V; d'Apice AJ
    J Biol Chem; 1991 Mar; 266(7):4593-7. PubMed ID: 1705556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated.
    Favaloro EJ; Browning T; Facey D
    Exp Hematol; 1993 Dec; 21(13):1695-701. PubMed ID: 7902291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells.
    Fontijn D; Duyndam MC; van Berkel MP; Yuana Y; Shapiro LH; Pinedo HM; Broxterman HJ; Boven E
    Br J Cancer; 2006 Jun; 94(11):1627-36. PubMed ID: 16685268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of CD13 expression on fresh myeloid leukaemia: correlation of CD13 expression with aminopeptidase-N activity.
    Razak K; Newland AC
    Leuk Res; 1992; 16(6-7):625-30. PubMed ID: 1353131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of aminopeptidase-N (CD13) and Fc epsilon RIIb (CD23) expression by IL-4 depends on the stage of maturation of monocytes/macrophages.
    Van Hal PT; Hopstaken-Broos JP; Wijkhuijs JM; Te Velde AA; Figdor CG; Hoogsteden HC
    J Immunol; 1992 Aug; 149(4):1395-401. PubMed ID: 1380041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies.
    Ashmun RA; Shapiro LH; Look AT
    Blood; 1992 Jun; 79(12):3344-9. PubMed ID: 1375850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of CD13 expression during retinoic acid-induced differentiation of HL60 cells.
    Razak K; Allen PD; Kelsey SM; Gutteridge CN; Newland AC
    Leuk Res; 1994 Aug; 18(8):629-36. PubMed ID: 7914950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity.
    Ino K; Goto S; Okamoto T; Nomura S; Nawa A; Isobe K; Mizutani S; Tomoda Y
    Jpn J Cancer Res; 1994 Sep; 85(9):927-33. PubMed ID: 7961121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
    Saitoh Y; Koizumi K; Minami T; Sekine K; Sakurai H; Saiki I
    Biol Pharm Bull; 2006 Apr; 29(4):709-12. PubMed ID: 16595904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix.
    van Hensbergen Y; Broxterman HJ; Peters E; Rana S; Elderkamp YW; van Hinsbergh VW; Koolwijk P
    Thromb Haemost; 2003 Nov; 90(5):921-9. PubMed ID: 14597989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis.
    Mishima T; Murata J; Toyoshima M; Fujii H; Nakajima M; Hayashi T; Kato T; Saiki I
    Clin Exp Metastasis; 1998 Aug; 16(6):541-50. PubMed ID: 9872601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.
    Kido A; Krueger S; Haeckel C; Roessner A
    Clin Exp Metastasis; 2003; 20(7):585-92. PubMed ID: 14669789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the aminopeptidase N (CD13) gene in the human T cell lines HuT78 and H9.
    Lendeckel U; Wex T; Kähne T; Frank K; Reinhold D; Ansorge S
    Cell Immunol; 1994 Jan; 153(1):214-26. PubMed ID: 7904539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 121.